期刊文献+

祛浊定眩汤治疗高血压病痰浊中阻证的临床研究

Clinical study of quzhuo dingxuan decoction in treating hypertension and turbidity
暂未订购
导出
摘要 目的研究祛浊定眩汤治疗高血压病痰浊中阻证的临床效果。方法根据随机数字表法将2017年5月至2018年10月期间本院接收的高血压病患者100例分为对照组和观察组,各50例。对照组采取苯磺酸左旋氨氯地平治疗,观察组在其基础上联合祛浊定眩汤治疗。将两组高血压病患者的血压水平、临床效果、不良反应发生情况进行对比。结果观察组高血压病患者治疗后的舒张压、收缩压以及不良反应发生率均低于对照组,临床总有效率显著高于对照组(P<0.05)。结论常规西药降压药物联合祛浊定眩汤对高血压病痰浊中阻证患者的治疗临床效果及降压效果均显著高于单用西医降压药物治疗,且用药安全性更高。 Objective To study the clinical effect of Quzhuo Dingxuan Decoction in the treatment of phlegm and blood stasis syndrome in patients with hypertension. Methods According to the random number table method, 100 patients with hypertension received from our hospital from May 2017 to October 2018 were divided into control group and observation group, with 50 cases in each group. The control group was treated with levosamine benzenesulfonate and the observation group was combined with phlegm-dampening decoction on the basis of treatment in control group. The blood pressure levels, clinical effects, and adverse reactions of the two groups of hypertensive patients were compared. Results The incidence of diastolic blood pressure, systolic blood pressure and adverse reactions in the observation group were lower than those in the control group. The total clinical effective rate was significantly higher than that in the control group (P<0.05). Conclusion The clinical effects and antihypertensive effects of conventional western medicine antihypertensive drugs combined with phlegm-dampening decoction for patients with hypertension and phlegm and blood stasis syndrome are significantly higher than those with anti-hypertensive drugs alone, and the safety of medication is higher.
作者 王磊 Wang Lei(Deparement of Cardiology, Jilin Province Jilin Integrated Traditional Chinese andWestern Medicine Hospital,Jilin, Jilin, 132000, China)
出处 《当代医学》 2019年第30期37-39,共3页 Contemporary Medicine
基金 吉林省中医药科技项目(2017277)
关键词 高血压病 痰浊中阻证 祛浊定眩汤 Hypertension Phlegm and stagnation syndrome Phlegm and dampness soup
  • 相关文献

参考文献6

二级参考文献41

  • 1李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1799
  • 2裴玉琨,周围血管病学[M].北京:北京科学技术出版社,1995:189.
  • 3李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:394
  • 4Pezzini A,Zotto ED, Padovani A.Homocysteine and cerebralischemia:pathogenic and therapeutical implications [J].Curr Me dChem, 2007,14(3):249-263.
  • 5Li Z,Sun L,Zhang H,et a/.Elevated plasma homocysteine wasassociated with hemorrhagic and ischemic stroke ,bulmethylenetelrahydrofolate reductase gene C677 T polymorphismwas a risk factor for thrombotic stroke:a Multicenter Case-ControlStudy in China[J].5zroAe, 2003,34( 9): 2085-2890.
  • 6Homocysteine Lowering TrialistsJ Collaboration.Dese -dependenteffects of folie acid on blood concentrations of homacysteine : ameta-analysis of the raldomized-als [J]Am J Clin 2005,82(4):806-812.
  • 7Figueirodo JC,Grau MV, Haile HW,e/ a7.Folic acid and risk ofprostate cancer;results from a raiuiomized clinical trial [J]J NatlCancer /noi,2009,101(6):432-435.
  • 8Tucker KL, Mahnken B, Wilson PWF, et al. Folic acidfortification of the food supply [J]. J Am Med Assocy 1996,276(23):1879-1885.
  • 9Toole JF, Malinow MR, Chambless LE, et al. Loweringhomocysteine in patients with ischemic stroke to preventrecurrent stroke, myocardial infarction, and death [J]. J Am Med^5soc,2004,291(5):565-575.
  • 10王昌郁,田绍巍,刘琦.不同剂量叶酸治疗高同型半胱氨酸血症疗效观察[J]?中外健康文摘,2012,47(8):231-232.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部